Abstract
Traditional cancer-survival analyses provide data on cancer management at the beginning of a study period, and are often not relevant to current practice because they refer to survival of patients treated with older regimens that might no longer be used. Therefore, shortening the delay in providing survival estimates is desirable. Period analysis can estimate cancer survival by the use of recent data. We aimed to apply the period-analysis method to data that were collected by European cancer registries to estimate recent survival by country and cancer site, and to assess survival changes in Europe. We also compared our findings with data on cancer survival in the USA from the US SEER (Surveillance, Epidemiology, and End Results) programme.
Original language | English |
---|---|
Pages (from-to) | 784-96 |
Number of pages | 13 |
Journal | The Lancet Oncology |
Volume | 8 |
Issue number | 9 |
DOIs | |
Publication status | Published - Sep 2007 |
Keywords
- Age of Onset
- Europe
- Health Surveys
- Humans
- Neoplasms
- Registries
- SEER Program
- Survival Analysis